Diseases and ConditionsNews - Page 2

Ireland’s largest cancer research programme enters new €28m phase

Ireland’s largest cancer research initiative, POI, launches a new €28m phase to advance personalised cancer care and precision oncology.

How artificial intelligence will supercharge transformative change for ALS drug discovery

Learn about the Longitude Prize on ALS, the personal story behind its creation, and how AI can help to transform treatment and care for ALS.

Restoring Roots: Transforming treatment for pulmonary hypertension

The Restoring Roots project emphasises the importance of addressing pulmonary hypertension, a serious condition that affects millions.

The SYNTHEMA project: Advancing AI-driven synthetic data for rare haematological diseases

SYNTHEMA enables GDPR-compliant research and innovation in rare haematological diseases. Discover more here.

USC study uncovers how PFAS damages human liver cells

New research reveals how PFAS chemicals disrupt human liver cells, causing fat buildup, immune interference, and cancer-related changes. They’re called ‘forever chemicals’ for a reason....

Sona: The importance of breast density monitoring

Dan Sarno, Founder and CTO at Sona, introduces the mobile breast density monitoring device aiming to enhance breast cancer detection.

UK launches £42.8m birth cohort study tracking 30,000 children from 2026

The Generation New Era birth cohort study will track 30,000 UK children from 2026 to transform early years policy and improve future lives.

University of Southampton study reveals major global inequalities in cancer research funding

Global cancer research funding is falling, with poorer nations missing out and vital treatments like surgery and radiotherapy underfunded.

Novel therapy for pets with head and neck cancers could now help humans

35% of cats who received treatment had their disease controlled, and the drug will likely be effective for humans with head and neck cancers.

£30m Darlington biofoundry to drive next-gen UK RNA therapies

A £30m UK biofoundry will fast-track next-gen RNA therapies, accelerating new treatments for cancer, heart disease and rare conditions.

UKHSA launches wastewater monitoring tech to catch pandemic threats

UKHSA labs will use wastewater monitoring technologies to detect and identify the genetic material of various viruses. Click to learn more.

NHS expands mobile liver scans to spot liver cancer earlier

NHS mobile liver scans are expanding across England, detecting liver damage earlier and helping thousands access life-saving cancer checks.

New study uncovers potential treatment target for rare lung cancer

A study from the University of Oklahoma has provided a new understanding of LCNEC, a rare and aggressive type of lung cancer.

New hope for glioblastoma multiforme: NuCapCure project targets deadliest brain tumour

Discover how the NuCapCure project is pioneering proton and neutron-based therapies to transform treatment for glioblastoma multiforme.

New NHS bladder cancer treatment doubles survival rates

A new NHS-approved bladder cancer treatment doubles survival rates and offers fresh hope for patients with advanced disease.

Warwick scientists’ diamond magnetic field sensor to transform cancer detection

Researchers at the University of Warwick have unveiled a diamond-based magnetic field sensor that promises to revolutionise cancer detection.

NHS fast-tracks mRNA vaccine trial for advanced head and neck cancer patients

NHS England is fast-tracking an mRNA vaccine trial for advanced head and neck cancer, offering new hope for patients. Find out more.

World Lung Cancer Day 2025: Commemorating, celebrating, supporting

On 1 August every year, organisations and people around the world commemorate World Lung Cancer Day to support those impacted by the disease.

Positive results for BioNxt’s cladribine sublingual thin-film

BioNxt Solutions has announced successful formulation of a sublingual thin-film prototype for its lead clinical stage candidate, BNT23001.

Optogenetic screening creates new opportunities for age-related diseases

Discover how a new platform combines optogenetics, chemistry, and AI to discover small-molecule therapeutics for age-related diseases.

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd